PubRank

N W Rodger

Author PubWeight™ 32.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984 3.47
2 Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes Relat Metab Disord 2004 2.54
3 The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med 1994 2.08
4 Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey. Br J Dermatol 1998 1.45
5 No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care 1998 1.42
6 Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes 1980 1.35
7 Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994 1.13
8 Low glycaemic index diet and disposition index in type 2 diabetes (the Canadian trial of carbohydrates in diabetes): a randomised controlled trial. Diabetologia 2008 1.01
9 Day-to-day consistency in amount and source of carbohydrate intake associated with improved blood glucose control in type 1 diabetes. J Am Coll Nutr 1999 1.00
10 Development of a theory-based daily activity intervention for individuals with type 2 diabetes. Diabetes Educ 2002 0.99
11 Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes. Int J Obes Relat Metab Disord 1997 0.89
12 Advances in insulin delivery in the management of diabetes mellitus. Clin Endocrinol Metab 1982 0.87
13 Acarbose in the treatment of elderly patients with type 2 diabetes. Diabetes Res Clin Pract 2003 0.85
14 Self-awareness in diabetes: using body cues, circumstances, and strategies. Diabetes Educ 1999 0.84
15 Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine. Diabetes 1991 0.83
16 Accuracy of capillary blood glucose values self-determined by diabetics under everyday conditions: comparison of visually-read and meter-read techniques. Clin Invest Med 1982 0.81
17 Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD). Nutr Metab Cardiovasc Dis 2012 0.80
18 One-year acarbose treatment raises fasting serum acetate in diabetic patients. Diabet Med 1995 0.80
19 Some factors indicative of hypertriglyceridemia in patients investigated for diabetes mellitus. Can Med Assoc J 1973 0.80
20 Metabolic response of forearm muscle to graded exercise in type II diabetes mellitus: effect of endurance training. Can J Appl Physiol 1996 0.77
21 Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Recruitment, Randomization, and baseline characteristics of the treatment groups. Diabetes 1985 0.76
22 Editorial: Diabetic hearts and biguanides-a reply. Can Med Assoc J 1976 0.75
23 Diagnosis of diabetes mellitus. Can Med Assoc J 1982 0.75
24 Anorexia nervosa with concealed hyperphagia and self-induced vomiting, hypokalemic alkalosis and normal aldosterone excretion. Can Med Assoc J 1970 0.75
25 Hazards in managing diabetic acidosis. Can Med Assoc J 1981 0.75
26 Managing diabetic ketoacidosis. Can Med Assoc J 1983 0.75
27 Changes in plasma insulin related to the type of dietary carbohydrate in overweight hyperlipidemic male patients. Can Med Assoc J 1971 0.75
28 Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions. Thromb Res 1982 0.75
29 Pregnancy in diabetic women: outcome with a program aimed at normoglycemia before meals. Can Med Assoc J 1981 0.75
30 Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease. J Pediatr 1987 0.75
31 Replacement treatment with insulin in diabetes mellitus: problems and promise. Clin Invest Med 1982 0.75
32 Insulin-mediated and non-insulin-mediated metabolic effects of gastroenteropancreatic peptides in type I and type II diabetes. Adv Exp Med Biol 1985 0.75
33 Decreased serum growth hormone concentrations in hypoxemic obese subjects. Clin Invest Med 1979 0.75
34 Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations. Diabetes Care 1985 0.75
35 TRH and bronchospasm. Lancet 1981 0.75
36 [Acceptance of new criteria for the diagnosis of diabetes mellitus and associated conditions]. Union Med Can 1981 0.75
37 Efficacy of continuous subcutaneous infusion of sulfated beef insulin. Diabetes Care 1984 0.75
38 Variability of response in the bioassay for a hypothalamic somatotrophin releasing factor based on rat pituitary growth hormone content. Endocrinology 1969 0.75
39 Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The Central Biochemistry Laboratory in the Multicenter Kroc Study. Problems and proposals. Diabetes 1985 0.75
40 The effect of valsartan and captopril on lipid parameters in patients with type II diabetes mellitus and nephropathy. Int J Clin Pract 1999 0.75
41 Decreased cardiac glycogen following phenformin injection in hyperglycemic, hyperinsulinemic anaesthetized rats. Adv Exp Med Biol 1977 0.75